CCL2 and Hyperglycemia: Further, liraglutide treatment significantly suppressed the hyperglycemia-enhanced vascular expression of Il-1, Tnf-α, and Tgf-β, and tended to reduce Il-6 and Mcp-1 levels (Fig. 9a–e).